Myda Advisors LLC Forte Biosciences, Inc. Transaction History

Myda Advisors LLC

  • $407 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$2.96 - $36.67 $59,200 - $733,400
-20,000 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$31.5 - $42.5 $252,000 - $340,000
-8,000 Reduced 28.57%
20,000 $672,000
Q4 2020

Feb 12, 2021
SELL
$28.66 - $46.79 $171,960 - $280,740
-6,000 Reduced 17.65%
28,000 $1.02 Million
Q3 2020

Nov 13, 2020
SELL
$14.71 - $50.69 $88,260 - $304,140
-6,000 Reduced 15.0%
34,000 $1.65 Million
Q2 2020

Aug 13, 2020
BUY
$13.9 - $24.6 $556,000 - $984,000
40,000 New
40,000 $583,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $114M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Myda Advisors LLC Portfolio

Follow Myda Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Myda Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email